These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37147720)

  • 1. Quality of life in women with chronic recurrent vulvovaginal candidosis: A sub-analysis of the prospective multicentre phase IIb/III Prof-001 study.
    Lietz A; Eckel F; Kiss H; Noe-Letschnig M; Farr A
    Mycoses; 2023 Sep; 66(9):767-773. PubMed ID: 37147720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA.
    Aballéa S; Guelfucci F; Wagner J; Khemiri A; Dietz JP; Sobel J; Toumi M
    Health Qual Life Outcomes; 2013 Oct; 11():169. PubMed ID: 24119427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life as measured with the Short-Form 36 (SF-36) questionnaire in patients with recurrent vulvovaginal candidiasis.
    Zhu YX; Li T; Fan SR; Liu XP; Liang YH; Liu P
    Health Qual Life Outcomes; 2016 Apr; 14():65. PubMed ID: 27129474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment for recurrent vulvovaginal candidiasis (thrush).
    Cooke G; Watson C; Deckx L; Pirotta M; Smith J; van Driel ML
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD009151. PubMed ID: 35005777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermasilk® briefs in recurrent vulvovaginal candidosis. An alternative option in long-lasting disease.
    D'Antuono A; Bellavista S; Gaspari V; Filippini A; Patrizi A
    Minerva Ginecol; 2013 Dec; 65(6):697-705. PubMed ID: 24346254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion.
    Donders G; Sziller IO; Paavonen J; Hay P; de Seta F; Bohbot JM; Kotarski J; Vives JA; Szabo B; Cepuliené R; Mendling W
    Front Cell Infect Microbiol; 2022; 12():934353. PubMed ID: 36159646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal pH and microbiota during fluconazole maintenance treatment for recurrent vulvovaginal candidosis (RVVC).
    Donders GG; Grinceviciene S; Ruban K; Bellen G
    Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115024. PubMed ID: 32253071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial.
    Oza AM; Matulonis UA; Malander S; Hudgens S; Sehouli J; Del Campo JM; Berton-Rigaud D; Banerjee S; Scambia G; Berek JS; Lund B; Tinker AV; Hilpert F; Vázquez IP; D'Hondt V; Benigno B; Provencher D; Buscema J; Agarwal S; Mirza MR
    Lancet Oncol; 2018 Aug; 19(8):1117-1125. PubMed ID: 30026000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of recurrent vulvovaginal candidiasis on quality of life issues.
    Fukazawa EI; Witkin SS; Robial R; Vinagre JG; Baracat EC; Linhares IM
    Arch Gynecol Obstet; 2019 Sep; 300(3):647-650. PubMed ID: 31270690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported impact of urinary incontinence--results from treatment seeking women in 14 European countries.
    Monz B; Pons ME; Hampel C; Hunskaar S; Quail D; Samsioe G; Sykes D; Wagg A; Papanicolaou S
    Maturitas; 2005 Nov; 52 Suppl 2():S24-34. PubMed ID: 16297579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-response to fluconazole maintenance treatment (ReCiDiF regimen) for recurrent vulvovaginal candidosis is not related to impaired glucose metabolism.
    Grinceviciene S; Bellen G; Ruban K; Donders G
    Mycoses; 2017 Aug; 60(8):546-551. PubMed ID: 28429840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonisation of extragenital sites by Candida in women with recurrent vulvovaginal candidosis.
    Mårdh PA; Novikova N; Stukalova E
    BJOG; 2003 Oct; 110(10):934-7. PubMed ID: 14550364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections.
    Martens MG; Maximos B; Degenhardt T; Person K; Curelop S; Ghannoum M; Flynt A; Brand SR
    Am J Obstet Gynecol; 2022 Dec; 227(6):880.e1-880.e11. PubMed ID: 35863457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent vulvovaginal candidosis: focus on the vulva.
    Beikert FC; Le MT; Koeninger A; Technau K; Clad A
    Mycoses; 2011 Nov; 54(6):e807-10. PubMed ID: 21615545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent vulvovaginal candidiasis.
    Sobel JD
    Am J Obstet Gynecol; 2016 Jan; 214(1):15-21. PubMed ID: 26164695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent Vulvovaginal Candidosis and Cluster Analysis of Clinical Signs and Symptoms: A Laboratory-Based Investigation.
    Ignjatović A; Arsić-Arsenijević V; Golubović M; Đenić S; Momčilović S; Trajković A; Ranđelović M; Ćirić V; Otašević S
    J Fungi (Basel); 2020 Jul; 6(3):. PubMed ID: 32707751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oteseconazole: an advance in treatment of recurrent vulvovaginal candidiasis.
    Sobel JD; Nyirjesy P
    Future Microbiol; 2021 Dec; 16():1453-1461. PubMed ID: 34783586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of the Quality of Life of People With Epilepsy Receiving Home-Based and Clinic-Based Epilepsy Care Using the European Quality of Life Five-Dimension Three-Level (EQ-5D-3L) Scale.
    Kalra S; Jiwan T; Singh G; Gautam PL; Bansal A
    Cureus; 2023 Feb; 15(2):e35045. PubMed ID: 36938287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic enzyme therapy in the treatment of recurrent vulvovaginal candidiasis].
    Unzeitig V; Dvořák V; Hlaváčková O; Malík T; Nový J; Stará A; Skřivánek A; Stěpán J
    Ceska Gynekol; 2013 Apr; 78(2):187-94. PubMed ID: 23710984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.